Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 224-748-4 | CAS number: 4474-24-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
LD50 = 8850 mg/kg bw (5664 mg/kg bw based on active ingtredient)
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- other: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- July 12, 1976
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- not specified
- GLP compliance:
- no
- Test type:
- standard acute method
- Species:
- rat
- Strain:
- other: Tif: RAIf
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 80 to 110 grams.
- Housing: During the treatment and observation period the animals were housed in groups of 5 in Macrolon cages1 (type 3) .
- Diet: standard diet of pellets - No. 890, Nafag Gossau SG, ad libitum
- Water: ad libitum
- Fasting period before study: Animals fasted overnight.
- Acclimation period: 5 days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 1 °C
- Humidity (%): 55 ± 5%
- Photoperiod (hrs dark / hrs light): 14 hours light cycle day. - Route of administration:
- oral: gavage
- Vehicle:
- other: sesame oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 10, 20, 25, and 30 % - Doses:
- 1000, 3000, 8000, 10000, 15000 mg/kg
- No. of animals per sex per dose:
- 5 x sex x doses
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: daily
- Necropsy of survivors performed: yes - Statistics:
- LD50 including 95% confidence limits was calculated by the probit analysis method (Goulden' A. , Methods of Statistical Analysis, John Wiley and Sons, 1960, 3rd printing, pages 404-408).
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- ca. 8 850 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- ca. 7 960 - ca. 9 900
- Remarks on result:
- other: 95% confidence limits
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- ca. 5 664 mg/kg bw
- Based on:
- act. ingr.
- Mortality:
- yes, for concentrations above 3000 mg/kg
- Clinical signs:
- other: diarrhea, ditto, reduction in spontaneous motility, ataxia, ventricumbency, muscular hypotonia, hypoventilation. Cyanosis for highest concentration (15000 mg/kg)
- Interpretation of results:
- other: CLP criteria not met
- Conclusions:
- LD50 = 8850 mg/kg bw (5664 mg/kg bw based on active ingtredient)
- Executive summary:
Method
The substance has been tested for acute toxicity by oral route. Rats of both sexes were tested at concetration of 1000, 3000, 8000, 10000, 15000 mg/kg by by oral intubation. Physical condition and rate of death were monitored throughout the whole observation period.
Conclusion
The compound has practically no acute toxicity to the rat by this route of administration.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Acute toxicity assessment
Three studies are available for the assessment of acute administration by oral route, two of them are on the substance, but lack of many details to be considered enough reliable. The Key study is a study on Similar Substance 02, well descibed and showing a clear dose/response relationship. More details about the similarity between the Target Substance and the Similar Substance 02 are described in the document attached to the IUCLID section 13.
The key study was conducted according to an official OECD method. The substance shows mortality for concentrations above 3000 mg/kg. Clinical signs are reported above 3000 mg/kg bw. The rats shows diarrhea, ditto, reduction in spontaneous motility, ataxia, ventricumbency, muscular hypotonia, hypoventilation. Cyanosis it is observed only for highest concentration (15000 mg/kg bw).
The LD50 value calculated in this test was 8850 mg/kg bw (5664 mg/kg bw based on active ingtredient).
The study performed in 1992 is a short summary, conducted with unknown method. The LD50 was 15000 mg/kg bw.
The study performed in 1973 is conducted with an unknown method. No clinical symptoms were recorded and no deaths occurred during the 14 day observation period. The LD50 was 8068.3 mg/kg bw.
Justification for classification or non-classification
According to the CLP Regulation (EC 1272/2008), substances can be allocated to one of four toxicity categories based on acute toxicity by the oral, dermal or inhalation route according to the numeric criteria. Acute toxicity values are expressed as (approximate) LD50 (oral, dermal) or LC50 (inhalation) values or as acute toxicity estimates (ATE).
In the case of oral exposure route, the acute toxicity hazard categories and acute toxicity estimates (ATE) defining the respective categories are:
- Category 1: ATE ≤ 5 mg/kg bw
- Category 2: 5 < ATE ≤ 50 mg/kg bw
- Category 3: 50 < ATE ≤ 300 mg/kg bw
- Category 4: 300 < ATE ≤ 2000 mg/kg bw
The acute oral LD50 in rats was established to be greater than 2000 mg/kg bw in all tests, therefore the substance is not classified for acute toxicity, according to the CLP Regulation (EC n. 1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.